January 29, 2026 · Form 4 insider transaction
Behrndt-Eriksen Mads Nikolaj bought 195,206 shares of Hemab Therapeutics Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 95 days after the transaction.
The warrant was granted on January 29, 2026. The shares underlying the warrant vest over four years, with 25% of the shares vesting on January 1, 2027 and the remaining shares vesting in equal monthly installments thereafter.